HCA Healthcare, Inc. (NYSE:HCA) Stake Reduced by Quotient Wealth Partners LLC

Quotient Wealth Partners LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 12.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 755 shares of the company’s stock after selling 105 shares during the period. Quotient Wealth Partners LLC’s holdings in HCA Healthcare were worth $227,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. MML Investors Services LLC increased its position in HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after acquiring an additional 4,285 shares during the period. Meritage Group LP bought a new stake in shares of HCA Healthcare during the third quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $18,044,000. Alpha DNA Investment Management LLC bought a new position in shares of HCA Healthcare in the third quarter valued at approximately $869,000. Finally, NRI Wealth Management LC bought a new stake in HCA Healthcare during the fourth quarter worth approximately $2,896,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on HCA. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Morgan Stanley reduced their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, KeyCorp reduced their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

Insiders Place Their Bets

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $318.28 on Tuesday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock has a fifty day moving average price of $313.75 and a 200 day moving average price of $353.51. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $80.62 billion, a price-to-earnings ratio of 14.49, a PEG ratio of 1.11 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business earned $5.90 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.90%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 12.02%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.